Aspiration Risk Patients who vomit while lying down, or who have reduced consciousness from dehydration, face a real aspiration risk
Glutathione Syrup (150ml) Autism friendly no bitter taste Brighten your skin tone with this master antioxidant
Data in humans are limited
Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
Patients with specific genetic profiles may show stronger response to one GLP-1 agonist versus another, yet most telehealth platforms prescribe based solely on clinical presentation and trial-and-error
Cruciferous vegetables, such as Brussels sprouts, broccoli, and collard greens, are healthy but should be eaten in moderation if sulfur burps become a problem
